文献速递食管胃疾病与幽门螺杆菌消化道肿瘤与早癌

系统综述与荟萃分析:一级亲属胃癌患者的胃癌风险

Systematic review and meta-analysis: Risk of gastric cancer in patients with first-degree relatives with gastric cancer.
PubMed 文献 · Aliment Pharmacol Ther · 2024-01-10

21项研究显示风险显著升高(OR=2.92,95%CI 2.402-3.552,p<0.001),但异质性较高(I2=81.85%)。结论强调家族史对早期检测的重要性。

要点

  • 一级亲属胃癌史使胃癌风险增加约3倍(OR=2.92)。
  • 该关联存在显著异质性(I2=81.85%)。
  • 家族史是早期检测肿瘤性疾病的重要风险因素。

核心结论

  • 一级亲属胃癌史与胃癌风险显著相关,OR=2.92(95%CI 2.402-3.552,p<0.001)。
  • 家族史是早期检测肿瘤性疾病的重要风险因素。

研究设计与样本

  • 两名评审独立提取数据,采用随机效应模型计算OR及95%CI,用I2量化异质性。

主要发现

  • 所有纳入研究中,一级亲属胃癌史均为胃癌风险因素。
  • 胃癌与一级亲属胃癌史之间关联显著增加,但研究间异质性显著(I2=81.85%,p<0.001)。

关键数值与推荐

  • OR=2.92(95%CI 2.402-3.552,p<0.001),对应一级亲属胃癌史与胃癌风险的关联。
  • I2=81.85%(p<0.001),对应研究间异质性。

临床怎么用

  • 临床应重视患者一级亲属胃癌史,将其作为早期检测肿瘤性疾病的风险因素。

局限性

  • 研究间异质性显著(I2=81.85%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastric cancer ranks fourth in terms of global cancer-related deaths. Timely identification of high-risk populations is crucial to reduce mortality. Although a family history of gastric cancer increases risk, European and British guidelines report weak recommendations and low-quality evidence about the management of these patients. AIM: To quantify the association in case-control studies of patients with gastric cancer with first-degree relatives with gastric cancer compared to those who do not. METHODS: We conducted a systematic review and meta-analysis of case-control studies up to November 2023. Data extraction was performed independently by two reviewers. The heterogeneity of effects across studies was quantified by I2 . We calculated odds ratios (OR) with 95% confidence intervals (CI) using random effects models. RESULTS: We included 30 studies in the systematic review. In all studies, a first-degree family history of gastric cancer represented a risk factor for gastric cancer. We included 21 studies on the risk of gastric cancer. There was a significantly increased association between gastric cancer and having first-degree relative(s) with gastric cancer, but with significant heterogeneity among studies (OR = 2.92; 95% CI 2.402-3.552; p < 0.001; I2 = 81.85%; p < 0.001). CONCLUSION: This meta-analysis highlights the relevance of patients' family history of gastric cancer and the importance of this risk factor for the early detection of neoplastic conditions.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Ligato I, Dottori L, Sbarigia C, et al. Systematic review and meta-analysis: Risk of gastric cancer in patients with first-degree relatives with gastric cancer. Aliment Pharmacol Ther. 2024. PMID: 38197125. doi:10.1111/apt.17872

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。